Kubo M - Search Results

1

Increased serum levels of soluble vascular cell adhesion molecule 1 and E-selectin in patients with localized scleroderma.

Yamane K, Ihn H, Kubo M, Yazawa N, Kikuchi K, Soma Y, Tamaki K. Yamane K, et al. Among authors: kubo m. J Am Acad Dermatol. 2000 Jan;42(1 Pt 1):64-9. doi: 10.1016/s0190-9622(00)90010-0. J Am Acad Dermatol. 2000. PMID: 10607321

2

Clinical and laboratory features of scleroderma patients with pulmonary hypertension.

Yamane K, Ihn H, Asano Y, Yazawa N, Kubo M, Kikuchi K, Soma Y, Tamaki K. Yamane K, et al. Among authors: kubo m. Rheumatology (Oxford). 2000 Nov;39(11):1269-71. doi: 10.1093/rheumatology/39.11.1269. Rheumatology (Oxford). 2000. PMID: 11085808

3

Blockade of endogenous transforming growth factor beta signaling prevents up-regulated collagen synthesis in scleroderma fibroblasts: association with increased expression of transforming growth factor beta receptors.

Ihn H, Yamane K, Kubo M, Tamaki K. Ihn H, et al. Among authors: kubo m. Arthritis Rheum. 2001 Feb;44(2):474-80. doi: 10.1002/1529-0131(200102)44:2<474::AID-ANR67>3.0.CO;2-#. Arthritis Rheum. 2001. PMID: 11229480 Free article.

4

Clinical significance of surfactant protein D as a serum marker for evaluating pulmonary fibrosis in patients with systemic sclerosis.

Asano Y, Ihn H, Yamane K, Yazawa N, Kubo M, Fujimoto M, Tamaki K. Asano Y, et al. Among authors: kubo m. Arthritis Rheum. 2001 Jun;44(6):1363-9. doi: 10.1002/1529-0131(200106)44:6<1363::AID-ART229>3.0.CO;2-5. Arthritis Rheum. 2001. PMID: 11407696 Free article.

5

Antibodies to Th/To ribonucleoprotein in patients with localized scleroderma.

Yamane K, Ihn H, Kubo M, Kuwana M, Asano Y, Yazawa N, Tamaki K. Yamane K, et al. Among authors: kubo m. Rheumatology (Oxford). 2001 Jun;40(6):683-6. doi: 10.1093/rheumatology/40.6.683. Rheumatology (Oxford). 2001. PMID: 11426027

6

Anti-U1RNP antibodies in patients with localized scieroderma.

Yamane K, Ihn H, Kubo M, Kuwana M, Asano Y, Yazawa N, Tamaki K. Yamane K, et al. Among authors: kubo m. Arch Dermatol Res. 2001 Sep;293(9):455-9. doi: 10.1007/s004030100254. Arch Dermatol Res. 2001. PMID: 11758788

7

Anti-U5 snRNP antibody as a possible serological marker for scleroderma-polymyositis overlap.

Kubo M, Ihn H, Kuwana M, Asano Y, Tamaki T, Yamane K, Tamaki K. Kubo M, et al. Rheumatology (Oxford). 2002 May;41(5):531-4. doi: 10.1093/rheumatology/41.5.531. Rheumatology (Oxford). 2002. PMID: 12011376

8

Decreased MMP-9 activity in the serum of patients with diffuse cutaneous systemic sclerosis.

Kikuchi K, Kubo M, Hoashi T, Tamaki K. Kikuchi K, et al. Among authors: kubo m. Clin Exp Dermatol. 2002 Jun;27(4):301-5. doi: 10.1046/j.1365-2230.2002.01011.x. Clin Exp Dermatol. 2002. PMID: 12139676

9

Clinical significance of serum surfactant protein D (SP-D) in patients with polymyositis/dermatomyositis: correlation with interstitial lung disease.

Ihn H, Asano Y, Kubo M, Yamane K, Jinnin M, Yazawa N, Fujimoto M, Tamaki K. Ihn H, et al. Among authors: kubo m. Rheumatology (Oxford). 2002 Nov;41(11):1268-72. doi: 10.1093/rheumatology/41.11.1268. Rheumatology (Oxford). 2002. PMID: 12421999

10

Clinical significance of serum matrix metalloproteinase-13 levels in patients with localized scleroderma.

Asano Y, Ihn H, Kubo M, Jinnin M, Mimura Y, Ashida R, Tamaki K. Asano Y, et al. Among authors: kubo m. Clin Exp Rheumatol. 2006 Jul-Aug;24(4):394-9. Clin Exp Rheumatol. 2006. PMID: 16956429

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,772 results

Search Page

Filters